221 related articles for article (PubMed ID: 30153192)
1. Hypertriglyceridemia: A review of the evidence.
Elkins C; Friedrich D
Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192
[TBL] [Abstract][Full Text] [Related]
2. Treating hypertriglyceridemia.
Holub BJ
CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
[No Abstract] [Full Text] [Related]
3. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
4. Drugs for hypertriglyceridemia.
Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
[No Abstract] [Full Text] [Related]
5. Treatment of hypertriglyceridemia: a review of current options.
Vrablík M; Češka R
Physiol Res; 2015; 64(Suppl 3):S331-40. PubMed ID: 26680666
[TBL] [Abstract][Full Text] [Related]
6. Approach to Hypertriglyceridemia in the Pediatric Population.
Valaiyapathi B; Sunil B; Ashraf AP
Pediatr Rev; 2017 Sep; 38(9):424-434. PubMed ID: 28864733
[TBL] [Abstract][Full Text] [Related]
7. Patient information page from The Hormone Foundations. Patient guide to the assessment and treatment of hypertriglyceridemia (high triglycerides).
Berglund L; Brunzell J; Sacks FM
J Clin Endocrinol Metab; 2012 Sep; 97(9):31A-32A. PubMed ID: 22962678
[No Abstract] [Full Text] [Related]
8. Treating hypertriglyceridemia.
Röggla G; Fasan M; Kapiotis S
CMAJ; 2007 Sep; 177(6):603; author reply 604-5. PubMed ID: 17846444
[No Abstract] [Full Text] [Related]
9. Triglycerides and endothelial function: molecular biology to clinical perspective.
Kajikawa M; Higashi Y
Curr Opin Lipidol; 2019 Oct; 30(5):364-369. PubMed ID: 31348023
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia: its etiology, effects and treatment.
Yuan G; Al-Shali KZ; Hegele RA
CMAJ; 2007 Apr; 176(8):1113-20. PubMed ID: 17420495
[TBL] [Abstract][Full Text] [Related]
11. Treating hypertriglyceridemia.
Yavasoglu I; Kadikoylu G; Bolaman Z
CMAJ; 2007 Sep; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
[No Abstract] [Full Text] [Related]
12. Hypertriglyceridemia and cardiovascular risk reduction.
Jacobson TA; Miller M; Schaefer EJ
Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
[TBL] [Abstract][Full Text] [Related]
13. [Multimodal therapy of dyslipidemia].
Stahn A; Hanefeld M
Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia and cardiovascular disease management.
Codario RA
J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
[No Abstract] [Full Text] [Related]
15. Recommendations for severe hypertriglyceridemia treatment, are there new strategies?
Filippatos TD; Elisaf MS
Curr Vasc Pharmacol; 2014; 12(4):598-616. PubMed ID: 23627980
[TBL] [Abstract][Full Text] [Related]
16. [Update: clinical lipidology].
Parhofer KG
MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
[No Abstract] [Full Text] [Related]
17. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.
Endocrine Society
Am Fam Physician; 2013 Jul; 88(2):142-4. PubMed ID: 23939649
[No Abstract] [Full Text] [Related]
18. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol.
Szapary PO; Rader DJ
Curr Opin Pharmacol; 2001 Apr; 1(2):113-20. PubMed ID: 11714084
[TBL] [Abstract][Full Text] [Related]
19. The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
Flink L; Underberg JA; Newman JD; Gianos E
Curr Atheroscler Rep; 2015 Apr; 17(4):494. PubMed ID: 25690588
[TBL] [Abstract][Full Text] [Related]
20. (8) Cardiovascular disease and risk management.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
